Characterisation of <it>CYP2C8</it>, <it>CYP2C9 </it>and <it>CYP2C19 </it>polymorphisms in a Ghanaian population
<p>Abstract</p> <p>Background</p> <p>Genetic influences on drug efficacy and tolerability are now widely known. Pharmacogenetics has thus become an expanding field with great potential for improving drug efficacy and reducing toxicity. Many pharmacologically-relevant po...
Main Authors: | Dodoo Alexander NO, Kudzi William, Mills Jeremy J |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-12-01
|
Series: | BMC Medical Genetics |
Online Access: | http://www.biomedcentral.com/1471-2350/10/124 |
Similar Items
-
Genetic polymorphisms in MDR1, CYP3A4 and CYP3A5 genes in a Ghanaian population: a plausible explanation for altered metabolism of ivermectin in humans?
by: Dodoo Alexander NO, et al.
Published: (2010-07-01) -
The relationship of drug plasma concentrations, and genetic polymorphisms of CYP2C9, CYP2C19, CYP2C18 and HLA in phenytoin hypersensitivity
by: Ying-Ying Wu, et al.
Published: (2010) -
Analysis of CYP2C9*2, CYP2C19*2, and CYP2D6*4 polymorphisms in patients with type 2 diabetes mellitus
by: Sabina Semiz, et al.
Published: (2010-11-01) -
The Effects of H2S on the Activities of CYP2B6, CYP2D6, CYP3A4, CYP2C19 and CYP2C9 in Vivo in Rat
by: Xianqin Wang, et al.
Published: (2013-12-01) -
Effects of CYP2C9 and CYP2C19 Polymorphisms on the Population Pharmacokinetics of Phenytoin in Taiwanese Patients with Epilepsy
by: 洪靚娟
Published: (2002)